GSC
AMED

Ground Swell Capital’s Amedisys AMED Stock Holding History

Ground Swell Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$48K Buy
+2,397
New +$46.2K 0.09% 228

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ground Swell Capital's AMED Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Amedisys (AMED) in Q3 2014: 2,397 shares worth $48K. The stake represents 0.09% of the portfolio and ranks #228 among its holdings.

125 funds tracked by Wall St. Rank hold AMED as of Q3 2014.

  • Ground Swell Capital held 2,397 shares of Amedisys worth $48K as of Q3 2014.
  • Amedisys was a new Ground Swell Capital position in Q3 2014.
  • Amedisys made up 0.09% of Ground Swell Capital's portfolio in Q3 2014, its #228 holding.
  • 125 funds tracked by Wall St. Rank held Amedisys as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.